德国生物制药商赛多利斯(Sartorius Aktiengesellschaft,SARTF)周四报告称,第三季度按公认会计准则计算的每股收益(EPS)为0.63欧元,营收为8.432亿欧元,同比增长6.3%。该公司更新了全年展望,预计集团销售额增长率约为7%。

本文地址: http://www.jiaotongmi.com/article/20267.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-11-04admin
2025-11-03admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-09-08admin
2025-09-13admin
2025-09-08admin
2025-09-17admin
2025-09-08admin
2025-09-17admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
扫码二维码
获取最新动态
